raps· 1d ago

Study: China outpaces the US in cancer approvals, lags behind on first approvals

July 20, 2026read original ↗

<p>While China's National Medical Products Administration (NMPA) approved more oncology drugs compared to the US Food and Drug Administration (FDA) from 2020 to 2025, the US regulator approved more first-in-class drugs and tended to approved products faster and earlier than China, according to a recent study published in Health Affairs.</p>

20 Jul 2026 MHRA touts uptick in approvals in 2025-2026 annual report The UK's Medicines and Healthcare products Regulatory Agency (MHRA) touted its achievements over the last year its 2025-2026 annual report to Parliament, which includes approving more new drugs than the prior year, removing a record number of illegal drugs from circulation, and taking steps to advance the regulation of artificial intelligence (AI) in healthcare. Regulatory News

68 words · extracted 14h agoread original ↗

🔗 mentioned in this article

no entities indexed yet

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?